CTI BioPharma
$0.94799876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.9479
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0101 (-1.05%) Today
$0.00 (0.00%) As of 6:36 PM EDT after-hours
Why Robinhood?
You can buy or sell CTI BioPharma and other stocks, options, ETFs, and crypto commission-free!
About CTIC
CTI BioPharma Corp. (DE) Common Stock, also called CTI BioPharma, is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. Read More It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.
Employees
25
Headquarters
Seattle, Washington
Founded
1991
Market Cap
69.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
21.07K
High Today
$0.958
Low Today
$0.90
Open Price
$0.958
Volume
69.75K
52 Week High
$1.92
52 Week Low
$0.6324
Collections
CTIC Earnings
-$0.58
-$0.38
-$0.19
$0.01
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 30, After Hours